Cargando…
Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line
Recently, with the purpose of enhancing the potency of epidermal growth factor receptor (EGFR)-based therapies, we designed a novel strategy termed ‘Cascade-release targeting’ that seeks to develop molecules capable of degrading to multiple tyrosine kinase (TK) inhibitors and highly reactive electro...
Autores principales: | Banerjee, R, Rachid, Z, Qiu, Q, McNamee, J P, Tari, A M, Jean-Claude, B J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747684/ https://www.ncbi.nlm.nih.gov/pubmed/15365562 http://dx.doi.org/10.1038/sj.bjc.6602098 |
Ejemplares similares
-
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
por: Hernes, E, et al.
Publicado: (2004) -
Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma
por: Abd El-Rehim, D M, et al.
Publicado: (2004) -
Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2(+) cancer patients
por: Shomura, H, et al.
Publicado: (2004) -
TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva
por: Rolfe, K J, et al.
Publicado: (2003) -
LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–PCR and immunohistochemical analysis
por: Thomasson, M, et al.
Publicado: (2003)